Ferroglobe Reports Results for the First Quarter of 2020
Ferroglobe Reports Results for the First Quarter of 2020
Sales of
- Q1 sales of
$311.2 million compared to$376.6 million in Q4 2019, and$447.4 million in Q1 2019 - Q1 net loss of
$(49.1) million compared to$(73.3) million in Q4 2019, and$(28.6) million in Q1 2019 - Adjusted EBITDA of
$(17.6) million compared to$(30.4) million in Q4 2019 and$3.3 million in Q1 2019 - Gross debt of
$443 million at the end of Q1 2020, compared to$481 million at the end of Q4 2019 - European accounts receivable securitization program amended on
February 6, 2020 , providing an increase in the available funding - Continued improvement in working capital during the quarter by
$126 million , with inventory levels decreasing by$67 million due to operational changes to the global production platform
Q1 2020 Earnings Highlights
In Q1 2020,
Q1 2020 reported EBITDA was
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | ||||||||||||||
Sales | $ | 311,223 | $ | 376,607 | $ | 447,391 | $ | 1,615,222 | |||||||||
Net (loss) profit | $ | (49,057 | ) | $ | (73,290 | ) | $ | (28,554 | ) | $ | (285,640 | ) | |||||
Diluted EPS | $ | (0.28 | ) | $ | (0.43 | ) | $ | (0.16 | ) | $ | (1.66 | ) | |||||
Adjusted net (loss) income attributable to the parent | $ | (37,714 | ) | $ | (45,613 | ) | $ | (21,894 | ) | $ | (105,811 | ) | |||||
Adjusted diluted EPS | $ | (0.22 | ) | $ | (0.27 | ) | $ | (0.13 | ) | $ | (0.64 | ) | |||||
Adjusted EBITDA | $ | (17,616 | ) | $ | (30,389 | ) | $ | 3,327 | $ | (29,236 | ) | ||||||
Adjusted EBITDA margin | -5.7% | -8.1% | 0.7% | -1.8% |
*Results for prior periods have been restated to reflect the impact of the profit(loss) from discontinued operations associated with the sale of former subsidiary FerroAtlántica S.A.U., the owner of hydroelectric assets in
Cash Flow and Balance Sheet
Cash generated from operations during Q1 2020 was $89.6 million, with working capital positively impacted by a decrease in inventories and trade receivables, offset by a decrease in payables. Working capital decreased from
Gross debt was
Recent developments
On
Subsequent to entering into the amended program, the Company has repaid
COVID-19
Since
While it is difficult to forecast the impacts of the COVID-19 pandemic, at the present time the Company’s day-to-day operations continue without being materially affected. The Company has evaluated, and will continue to evaluate, how evolving demand from its customer base and sales price evolution stand to affect the Company’s business and results in the next twelve months.
Subsequent events
On
Discussion of First Quarter 2020 Results
Sales
Sales for Q1 2020 were
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | ||||||||||||||||
Change | Change | ||||||||||||||||||
Shipments in metric tons: | |||||||||||||||||||
Silicon Metal | 53,321 | 63,113 | -15.5 | % | 62,269 | -14.4 | % | 239,692 | |||||||||||
Silicon-based Alloys | 60,932 | 64,485 | -5.5 | % | 81,801 | -25.5 | % | 295,429 | |||||||||||
Manganese-based Alloys | 73,724 | 95,235 | -22.6 | % | 103,669 | -28.9 | % | 392,456 | |||||||||||
Total shipments* | 187,977 | 222,833 | -15.6 | % | 247,739 | -24.1 | % | 927,577 | |||||||||||
Average selling price ($/MT): | |||||||||||||||||||
Silicon Metal | $ | 2,212 | $ | 2,164 | 2.2 | % | $ | 2,358 | -6.2 | % | $ | 2,252 | |||||||
Silicon-based Alloys | $ | 1,474 | $ | 1,424 | 3.5 | % | $ | 1,669 | -11.7 | % | $ | 1,547 | |||||||
Manganese-based Alloys | $ | 973 | $ | 1,054 | -7.7 | % | $ | 1,172 | -17.0 | % | $ | 1,140 | |||||||
Total* | $ | 1,487 | $ | 1,475 | 0.8 | % | $ | 1,634 | -9.0 | % | $ | 1,557 | |||||||
Average selling price ($/lb.): | |||||||||||||||||||
Silicon Metal | $ | 1.00 | $ | 0.98 | 2.2 | % | $ | 1.07 | -6.2 | % | $ | 1.02 | |||||||
Silicon-based Alloys | $ | 0.67 | $ | 0.65 | 3.5 | % | $ | 0.76 | -11.7 | % | $ | 0.70 | |||||||
Manganese-based Alloys | $ | 0.44 | $ | 0.48 | -7.7 | % | $ | 0.53 | -17.0 | % | $ | 0.52 | |||||||
Total* | $ | 0.67 | $ | 0.67 | 0.8 | % | $ | 0.74 | -9.0 | % | $ | 0.71 |
* Excludes by-products and other
Sales Prices & Volumes By Product
During Q1 2020, total product average selling prices increased by 0.8% versus Q4 2019. Q1 average selling prices of silicon metal increased 2.2%, silicon-based alloys prices increased 3.5%, and manganese-based alloys prices decreased 7.7%.
Sales volumes in Q1 declined by 15.6% versus the prior quarter. Q1 sales volumes of silicon metal decreased 15.5%, silicon-based alloys decreased 5.5%, and manganese-based alloys decreased 22.6% versus Q4 2019.
Reduced activity due to the temporary shutdown of some plants in
Cost of Sales
Cost of sales was
Other Operating Expenses
Other operating expenses was
Net Loss Attributable to the Parent
In Q1 2020, net loss attributable to the Parent was
Adjusted EBITDA
In Q1 2020, adjusted EBITDA was
Conference Call
Ferroglobe management will review the first quarter during a conference call at 9:00 a.m. Eastern Time on
The dial-in number for participants in the United States is 877‑293‑5491 (conference ID 7299897). International callers should dial +1 914‑495‑8526 (conference ID 7299897). Please dial in at least five minutes prior to the call to register. The call may also be accessed via an audio webcast available at https://edge.media-server.com/mmc/p/tvypsrbz.
About Ferroglobe
Ferroglobe is one of the world’s leading suppliers of silicon metal, silicon-based and manganese-based specialty alloys and other ferroalloys, serving a customer base across the globe in dynamic and fast-growing end markets, such as solar, automotive, consumer products, construction and energy. The Company is based in London. For more information, visit http://investor.ferroglobe.com.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of
Forward-looking statements contained in this press release are based on information currently available to the Company and assumptions that management believe to be reasonable, but are inherently uncertain. As a result, Ferroglobe’s actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements, which are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company’s control.
Forward-looking financial information and other metrics presented herein represent the Company’s goals and are not intended as guidance or projections for the periods referenced herein or any future periods.
All information in this press release is as of the date of its release. Ferroglobe does not undertake any obligation to update publicly any of the forward-looking statements contained herein to reflect new information, events or circumstances arising after the date of this press release. You should not place undue reliance on any forward-looking statements, which are made only as of the date of this press release.
Non-IFRS Measures
Adjusted EBITDA, adjusted EBITDA margin, adjusted net profit, adjusted profit per share, working capital and net debt, are non-IFRS financial metrics that, we believe, are pertinent measures of Ferroglobe’s success.
INVESTOR CONTACT:
EVP – Investor Relations
Email: investor.relations@ferroglobe.com
Managing Director
Hayden IR
Tel: 1-774-291-6000
Email: louie@haydenir.com
Unaudited Condensed Consolidated Income Statement
(in thousands of
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | |||||||||||||
Sales | $ | 311,223 | $ | 376,607 | $ | 447,391 | $ | 1,615,222 | ||||||||
Cost of sales | (243,360 | ) | (314,905 | ) | (329,368 | ) | (1,214,397 | ) | ||||||||
Other operating income | 7,768 | 12,446 | 14,021 | 54,213 | ||||||||||||
Staff costs | (55,097 | ) | (63,378 | ) | (74,263 | ) | (285,029 | ) | ||||||||
Other operating expense | (40,067 | ) | (58,804 | ) | (53,917 | ) | (225,705 | ) | ||||||||
Depreciation and amortization charges, operating allowances and write-downs | (28,668 | ) | (30,029 | ) | (30,370 | ) | (120,194 | ) | ||||||||
Impairment losses | — | (547 | ) | (140 | ) | (175,899 | ) | |||||||||
Bargain purchase gain | — | — | — | — | ||||||||||||
Other gain (loss) | (671 | ) | 100 | (397 | ) | (3,797 | ) | |||||||||
Operating (loss) profit | (48,872 | ) | (78,510 | ) | (27,043 | ) | (355,586 | ) | ||||||||
Net finance expense | (16,484 | ) | (16,484 | ) | (13,823 | ) | (61,845 | ) | ||||||||
Financial derivatives (loss) gain | 3,168 | (1,153 | ) | 1,264 | 2,729 | |||||||||||
Exchange differences | 2,436 | 4,366 | (1,479 | ) | 2,884 | |||||||||||
(Loss) profit before tax | (59,753 | ) | (91,781 | ) | (41,081 | ) | (411,818 | ) | ||||||||
Income tax benefit (expense) | 10,696 | 14,119 | 8,210 | 41,541 | ||||||||||||
(Loss) profit for the period from continuing operations | (49,057 | ) | (77,662 | ) | (32,871 | ) | (370,277 | ) | ||||||||
Profit for the period from discontinued operations | — | 4,372 | 4,317 | 84,637 | ||||||||||||
(Loss) profit for the period | (49,057 | ) | (73,290 | ) | (28,554 | ) | (285,640 | ) | ||||||||
Loss (profit) attributable to non-controlling interest | 1,159 | 866 | 1,724 | 5,039 | ||||||||||||
(Loss) profit attributable to the parent | $ | (47,898 | ) | $ | (72,424 | ) | $ | (26,830 | ) | $ | (280,601 | ) | ||||
EBITDA | $ | (20,204 | ) | $ | (48,481 | ) | $ | 3,327 | $ | (235,392 | ) | |||||
Adjusted EBITDA | $ | (17,617 | ) | $ | (30,390 | ) | $ | 3,327 | $ | (29,236 | ) | |||||
Weighted average shares outstanding | ||||||||||||||||
Basic | 169,249 | 169,182 | 169,123 | 169,153 | ||||||||||||
Diluted | 169,249 | 169,182 | 169,123 | 169,153 | ||||||||||||
(Loss) profit per ordinary share | ||||||||||||||||
Basic | $ | (0.28 | ) | $ | (0.43 | ) | $ | (0.16 | ) | $ | (1.66 | ) | ||||
Diluted | $ | (0.28 | ) | $ | (0.43 | ) | $ | (0.16 | ) | $ | (1.66 | ) |
*Throughout the results, the amounts for prior periods have been restated to reflect the impact of the profit/(loss) from discontinued operations associated with the sale of FerroAtlántica S.A.U., owner of hydroelectric assets in
Unaudited Condensed Consolidated Statement of Financial Position
(in thousands of
2020 | 2019 | 2019 | ||||||||
ASSETS | ||||||||||
Non-current assets | ||||||||||
$ | 29,702 | $ | 29,702 | $ | 203,472 | |||||
Other intangible assets | 50,373 | 51,267 | 69,399 | |||||||
Property, plant and equipment | 689,383 | 740,906 | 890,436 | |||||||
Other non-current financial assets | 5,683 | 2,618 | 54,979 | |||||||
Deferred tax assets | 65,360 | 59,551 | 7,135 | |||||||
Non-current receivables from related parties | 2,191 | 2,247 | 2,247 | |||||||
Other non-current assets | 1,520 | 1,597 | 10,435 | |||||||
Non-current restricted cash and cash equivalents | 28,173 | 28,323 | — | |||||||
Total non-current assets | 872,385 | 916,211 | 1,238,103 | |||||||
Current assets | ||||||||||
Inventories | 287,258 | 354,121 | 451,753 | |||||||
Trade and other receivables | 216,970 | 309,064 | 127,992 | |||||||
Current receivables from related parties | 2,895 | 2,955 | 6,556 | |||||||
Current income tax assets | 16,298 | 27,930 | 26,855 | |||||||
Other current financial assets | 5,062 | 5,544 | 2,191 | |||||||
Other current assets | 16,113 | 23,676 | 13,721 | |||||||
Cash and cash equivalents * | 116,316 | 94,852 | 216,627 | |||||||
Total current assets | 660,912 | 818,142 | 845,695 | |||||||
Total assets | $ | 1,533,297 | $ | 1,734,353 | $ | 2,083,798 | ||||
EQUITY AND LIABILITIES | ||||||||||
Equity | $ | 525,117 | $ | 602,297 | $ | 855,099 | ||||
Non-current liabilities | ||||||||||
Deferred income | 9,081 | 1,253 | 11,676 | |||||||
Provisions | 79,135 | 84,852 | 76,613 | |||||||
Bank borrowings | 111,583 | 144,388 | 131,366 | |||||||
Lease liabilities | 14,642 | 16,972 | 66,992 | |||||||
Debt instruments | 344,639 | 344,014 | 342,222 | |||||||
Other financial liabilities | 32,702 | 43,157 | 27,109 | |||||||
Other non-current liabilities | 26,817 | 25,906 | 25,080 | |||||||
Deferred tax liabilities | 69,084 | 74,057 | 61,887 | |||||||
Total non-current liabilities | 687,683 | 734,599 | 742,945 | |||||||
Current liabilities | ||||||||||
Provisions | 34,853 | 46,091 | 47,619 | |||||||
Bank borrowings | 1,369 | 14,611 | 19,100 | |||||||
Lease liabilities | 8,932 | 8,900 | 20,616 | |||||||
Debt instruments | 2,820 | 10,937 | 2,734 | |||||||
Other financial liabilities | 23,101 | 23,382 | 51,618 | |||||||
Payables to related parties | 4,572 | 4,830 | 12,199 | |||||||
Trade and other payables | 156,634 | 189,229 | 228,649 | |||||||
Current income tax liabilities | 1,485 | 3,048 | 4,369 | |||||||
Other current liabilities | 86,731 | 96,429 | 98,850 | |||||||
Liabilities associated with assets classified as held for sale | — | — | — | |||||||
Total current liabilities | 320,497 | 397,457 | 485,754 | |||||||
Total equity and liabilities | $ | 1,533,297 | $ | 1,734,353 | $ | 2,083,798 |
*Cash and cash equivalents at
Unaudited Condensed Consolidated Statement of Cash Flows
(in thousands of
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | ||||||||||||||
Cash flows from operating activities: | |||||||||||||||||
(Loss) profit for the period | $ | (49,057 | ) | $ | (73,289 | ) | $ | (28,554 | ) | $ | (285,640 | ) | |||||
Adjustments to reconcile net (loss) profit to net cash used by operating activities: |
|||||||||||||||||
Income tax (benefit) expense | (10,696 | ) | (14,120 | ) | (6,704 | ) | (40,528 | ) | |||||||||
Depreciation and amortization charges, operating allowances and write-downs |
28,668 | 30,029 | 32,077 | 123,024 | |||||||||||||
Net finance expense | 16,484 | 16,485 | 14,756 | 68,279 | |||||||||||||
Financial derivatives loss (gain) | (3,168 | ) | 1,153 | (1,264 | ) | (2,729 | ) | ||||||||||
Exchange differences | (2,436 | ) | (4,366 | ) | 1,479 | (2,884 | ) | ||||||||||
Impairment losses | — | 546 | 140 | 175,899 | |||||||||||||
Bargain purchase gain | — | — | — | — | |||||||||||||
Gain on disposal of discontinued operation | — | (4,372 | ) | — | (85,101 | ) | |||||||||||
Share-based compensation | 722 | 1,599 | 1,332 | 4,879 | |||||||||||||
Other adjustments | 671 | (99 | ) | 397 | 3,797 | ||||||||||||
Changes in operating assets and liabilities | |||||||||||||||||
(Increase) decrease in inventories | 51,577 | 132,493 | 35 | 91,531 | |||||||||||||
(Increase) decrease in trade receivables | 83,832 | 29,310 | 28,371 | 30,933 | |||||||||||||
Increase (decrease) in trade payables | (25,504 | ) | (51,152 | ) | (22,967 | ) | (63,187 | ) | |||||||||
Other | (11,598 | ) | (24,448 | ) | 9,787 | (45,878 | ) | ||||||||||
Income taxes paid | 10,119 | (523 | ) | (1,680 | ) | (3,589 | ) | ||||||||||
Net cash provided (used) by operating activities | 89,614 | 39,246 | 27,205 | (31,194 | ) | ||||||||||||
Cash flows from investing activities: | |||||||||||||||||
Interest and finance income received | 254 | 171 | 390 | 1,673 | |||||||||||||
Payments due to investments: | |||||||||||||||||
Acquisition of subsidiary | — | — | — | 9,088 | |||||||||||||
Other intangible assets | — | — | (134 | ) | (184 | ) | |||||||||||
Property, plant and equipment | (4,606 | ) | (5,600 | ) | (13,448 | ) | (32,445 | ) | |||||||||
Other | — | (621 | ) | — | (1,248 | ) | |||||||||||
Disposals: | |||||||||||||||||
Disposal of subsidiaries | — | 5,532 | — | 176,590 | |||||||||||||
Other non-current assets | — | 8,668 | — | 8,668 | |||||||||||||
Other | — | 352 | 1,759 | 3,768 | |||||||||||||
Net cash (used) provided by investing activities | (4,352 | ) | 8,502 | (11,433 | ) | 165,910 | |||||||||||
Cash flows from financing activities: | |||||||||||||||||
Dividends paid | — | — | — | ||||||||||||||
Payment for debt issuance costs | (1,576 | ) | (12,319 | ) | (705 | ) | (15,117 | ) | |||||||||
Repayment of hydro leases | — | — | — | (55,352 | ) | ||||||||||||
Repayment of other financial liabilities | — | — | — | — | |||||||||||||
Increase/(decrease) in bank borrowings: | — | — | — | ||||||||||||||
Borrowings | — | 174,130 | 31,850 | 245,629 | |||||||||||||
Payments | (44,880 | ) | (269,400 | ) | (20,811 | ) | (329,501 | ) | |||||||||
Proceeds from stock option exercises | — | — | — | — | |||||||||||||
Other amounts paid due to financing activities | 1,147 | (4,363 | ) | (5,708 | ) | (26,631 | ) | ||||||||||
Payments to acquire or redeem own shares | — | — | — | — | |||||||||||||
Interest paid | (18,824 | ) | (2,471 | ) | (18,508 | ) | (43,033 | ) | |||||||||
Net cash (used) provided by financing activities | (64,133 | ) | (114,423 | ) | (13,882 | ) | (224,005 | ) | |||||||||
Total net cash flows for the period | 21,129 | (66,675 | ) | 1,890 | (89,289 | ) | |||||||||||
Beginning balance of cash and cash equivalents | 123,175 | 188,043 | 216,647 | 216,647 | |||||||||||||
Exchange differences on cash and cash equivalents in foreign currencies |
185 | 1,807 | (1,910 | ) | (4,183 | ) | |||||||||||
Ending balance of cash and cash equivalents | $ | 144,489 | $ | 123,175 | $ | 216,627 | $ | 123,175 | |||||||||
Cash from continuing operations | 116,316 | 94,852 | 216,627 | 94,852 | |||||||||||||
Non-current restricted cash and cash equivalents | 28,173 | 28,323 | — | 28,323 | |||||||||||||
Cash and restricted cash in the statement of financial position | $ | 144,489 | $ | 123,175 | $ | 216,627 | $ | 123,175 |
* While in previous periods
Adjusted EBITDA ($,000):
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | ||||||||||||||
(Loss) profit attributable to the parent | $ | (47,898 | ) | $ | (72,424 | ) | $ | (26,830 | ) | $ | (280,601 | ) | |||||
(Loss) profit for the period from discontinued operations | — | (4,372 | ) | (4,317 | ) | (84,637 | ) | ||||||||||
Loss (profit) attributable to non-controlling interest | (1,159 | ) | (866 | ) | (1,724 | ) | (5,039 | ) | |||||||||
Income tax (benefit) expense | (10,696 | ) | (14,119 | ) | (8,210 | ) | (41,541 | ) | |||||||||
Net finance expense | 16,484 | 16,484 | 13,823 | 61,845 | |||||||||||||
Financial derivatives loss (gain) | (3,168 | ) | 1,153 | (1,264 | ) | (2,729 | ) | ||||||||||
Exchange differences | (2,436 | ) | (4,366 | ) | 1,479 | (2,884 | ) | ||||||||||
Depreciation and amortization charges, operating allowances and write-downs | 28,668 | 30,029 | 30,370 | 120,194 | |||||||||||||
EBITDA | (20,205 | ) | (48,481 | ) | 3,327 | (235,392 | ) | ||||||||||
Impairment | — | 456 | — | 174,464 | |||||||||||||
Revaluation of biological assets | — | (550 | ) | — | 530 | ||||||||||||
Contract termination costs | — | — | — | 9,260 | |||||||||||||
Restructuring and termination costs | — | 3,000 | — | 5,894 | |||||||||||||
Energy: |
125 | 9,682 | — | 9,682 | |||||||||||||
Energy: |
— | 3,645 | — | 3,645 | |||||||||||||
Staff Costs: |
155 | 327 | — | 327 | |||||||||||||
Other Idling Costs | 2,308 | 1,532 | — | 1,532 | |||||||||||||
(Loss)profit on disposal of non-core businesses | — | — | — | 822 | |||||||||||||
Bargain purchase gain | — | — | — | — | |||||||||||||
Share-based compensation | — | — | — | — | |||||||||||||
Adjusted EBITDA | $ | (17,617 | ) | $ | (30,389 | ) | $ | 3,327 | $ | (29,236 | ) |
*Throughout the results, amounts for prior periods have been restated to reflect the impact of the profit/ (loss) from discontinued operations associated with the sale of FerroAtlántica S.A.U., owner of hydroelectric assets in
Adjusted profit attributable to
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | ||||||||||||||
(Loss) profit attributable to the parent | $ | (47,898 | ) | $ | (72,424 | ) | $ | (26,830 | ) | $ | (280,601 | ) | |||||
Tax rate adjustment | 8,425 | 15,251 | 4,936 | 90,241 | |||||||||||||
Impairment | — | 310 | — | 118,636 | |||||||||||||
Revaluation of biological assets | — | (374 | ) | — | 360 | ||||||||||||
Contract termination costs | — | — | — | 6,297 | |||||||||||||
Restructuring and termination costs | — | 2,040 | — | 4,008 | |||||||||||||
Energy: |
85 | 6,584 | — | 6,584 | |||||||||||||
Energy: |
— | 2,479 | — | 2,479 | |||||||||||||
Staff Costs: |
105 | 222 | — | 222 | |||||||||||||
Other Idling Costs | 1,569 | 1,042 | — | 1,042 | |||||||||||||
(Loss) profit on disposal of non-core businesses | — | (743 | ) | — | (55,079 | ) | |||||||||||
Bargain purchase gain | — | — | — | — | |||||||||||||
Share-based compensation | — | — | — | — | |||||||||||||
Adjusted (loss) profit attributable to the parent | $ | (37,714 | ) | $ | (45,613 | ) | $ | (21,894 | ) | $ | (105,811 | ) |
Adjusted diluted profit per share:
Quarter Ended | Quarter Ended | Quarter Ended | Year Ended | ||||||||||||||
Diluted (loss) profit per ordinary share | $ | (0.28 | ) | $ | (0.43 | ) | $ | (0.16 | ) | $ | (1.66 | ) | |||||
Tax rate adjustment | 0.05 | 0.09 | 0.03 | 0.53 | |||||||||||||
Impairment | — | 0.00 | — | 0.70 | |||||||||||||
Revaluation of biological assets | — | (0.00 | ) | — | 0.00 | ||||||||||||
Contract termination costs | — | — | — | 0.04 | |||||||||||||
Restructuring and termination costs | — | 0.01 | — | 0.02 | |||||||||||||
Energy: |
0.00 | 0.04 | — | 0.04 | |||||||||||||
Energy: |
— | 0.01 | — | 0.01 | |||||||||||||
Staff Costs: |
0.00 | 0.00 | — | 0.00 | |||||||||||||
Other Idling Costs | 0.01 | 0.01 | — | 0.01 | |||||||||||||
(Loss) profit on disposal of non-core businesses | — | (0.00 | ) | — | (0.33 | ) | |||||||||||
Bargain purchase gain | — | — | — | — | |||||||||||||
Share-based compensation | — | — | — | — | |||||||||||||
Adjusted diluted (loss) profit per ordinary share | $ | (0.22 | ) | $ | (0.27 | ) | $ | (0.13 | ) | $ | (0.64 | ) |
Source: Ferroglobe PLC